Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › ONESOURCE

ONESOURCE

Onesource Specialty Pharma Limited
Small-capHealthcare ↗

What the six lenses say about ONESOURCE — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹1625.7
2026-07-10
VWAP · 1Y anchor
₹1603
+1.4% from VWAP
P/E · TTM
-64.7×
TTM EPS ₹-25.1
52-week range
56%
position low→high
RSI(14)
45
momentum

Own sector index

Healthcare ↗
Overweight

1M

+5.5%

3M

+14.9%

1Y

+12.8%

Breadth >EMA21

68%

How ONESOURCE’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
5.0
avg conviction decile
Leadership
0/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD338›

The actual numbers

Price vs VWAP (1y)+1.4%
EMA trend stackMixed
Price vs 200-EMA-0.6%
Price vs 50-EMA-2.1%
RSI(14)45
RS vs Nifty 500 · 3M+9.7%
RS vs sector · 3M-1.9%
52-week range56%
Volume vs 30d avg3.49×
Volume vs 60d avg2.12×
ATR(14) · volatility76.8
Bollinger width · vol contraction0.084
FundamentalD18›

The actual numbers

Return on equity (ROE)-1.1%
Return on capital (ROCE)0.6%
Net margin-17.5%

Full 8-quarter history in the financials table below.

ValuationD847›

The actual numbers

P/E (TTM)-64.7×
TTM EPS₹-25.1
52-week range56%
CatalystD538›

The actual numbers

Earnings & momentum39
Capital actions12
Governance87

Every filing in the corporate-announcements panel below.

FlowD750›

The actual numbers

Promoter holding30.5%
Delivery · 30d avg48.9%
Up/down-day asymmetry0.7pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D3 + D7 ) ÷ 2 = 5.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Watch
39
Conviction score 39/100 · avg-decile strength 5.0/10
Conviction score39/100›
TechnicalD3›
FundamentalD1›
ValuationD8›
CatalystD5›
FlowD7›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+0.5pp
-2.8pp
-7.6pp
+13.3pp
-1.0pp
-13.0pp
Nifty 500
Broad-market baseline
+0.1pp
-2.9pp
-8.2pp
+9.7pp
-6.0pp
-16.8pp
Sector
Own-sector index
—
—
-9.9pp
-1.9pp
-18.8pp
-31.3pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

ONESOURCE daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
1625.70+13.70

Relative strength

RS vs baseline · rebased to 100

ONESOURCE ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
87.81+0.08

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricSep '24Dec '24
Revenue (₹cr)68393
↳ change QoQ—+477.5%
EBITDA (₹cr)148
EBITDA margin1.0%12.3%
PAT (₹cr)-39-69
↳ change QoQ—-75.1%
Net margin-57.9%-17.5%
EPS (₹)-18.82-6.31
D/E——
YoY growth · Dec '24Revenue n/aPAT n/a

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 17 Jun '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 May '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 May '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 16 May '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 May '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 13 May '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 13 May '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 May '26
    HIGHgovernance
    Change in Auditors
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 May '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 May '26
    MEDIUMgovernance
    Resignation
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 May '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 7 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 4 May '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds ONESOURCE

Mutual funds holding ONESOURCE (10)

FundWeightAUM ₹crGrade
Axis Small Cap Fund Reg Gr0.60%27,840
Motilal Oswal Large & Midcap Reg Gr4.05%17,420
Motilal Oswal Flexicap Reg Gr3.06%12,937
Axis Flexi Cap Reg Gr0.87%12,625
Motilal Oswal Small Cap Reg Gr1.41%6,515
JM Flexicap Gr0.74%5,069
Motilal Oswal ELSS Tax Saver Reg Gr4.78%4,663
Mirae Asset Small Cap Reg Gr0.83%4,381
Mirae Asset Healthcare Reg Gr3.26%3,091
360 ONE Flexicap Reg Gr1.98%2,042

ETFs holding ONESOURCE (3)

ETFWeightGrade
Motilal Oswal BSE Select IPO ETF0.94%
Mirae Asset Nifty 500 Healthcare ETF0.80%
Motilal Oswal BSE Healthcare ETF0.68%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare